# 123I Radiolabeled 3BNC117

> **NCT03468582** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Lausanne Hospitals** · enrollment: 6 (actual)

## Conditions studied

- Human Immunodeficiency Virus

## Interventions

- **COMBINATION_PRODUCT:** 123I radiolabeled 3BNC117

## Key facts

- **NCT ID:** NCT03468582
- **Lead sponsor:** University of Lausanne Hospitals
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-08
- **Primary completion:** 2020-01-28
- **Final completion:** 2020-01-28
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2020-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03468582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03468582, "123I Radiolabeled 3BNC117". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03468582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*